|
|
Volumn 11, Issue SUPPL. 1, 2001, Pages 31-33
|
|
The integration of docetaxel into first-line chemotherapy for ovarian cancer
|
|
Author keywords
Docetaxel; First line; Ovarian cancer
|
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
PACLITAXEL;
ANTINEOPLASTIC ACTIVITY;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER RESISTANCE;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG INFUSION;
HUMAN;
NEUROTOXICITY;
OVARY CANCER;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AREA UNDER CURVE;
CARBOPLATIN;
CISPLATIN;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
PACLITAXEL;
RANDOMIZED CONTROLLED TRIALS;
TAXOIDS;
TREATMENT OUTCOME;
|
|
EID: 0034889998
PISSN: 1048891X
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1525-1438.2001.11(suppl.1)sup1031.x Document Type: Conference Paper |
|
Times cited : (17)
|
|
References (11)
|
